Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study

Author： Carizza Carlos   Abdelmassih Vicente   Abdelmassih Soraya   Ravizzini Pedro   Salgueiro Lister   Salgueiro Paulo Tudech   Jine Lin Tao   Nagy Peter   Abdelmassih Roger  

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.17, Iss.6, 2008-12, pp. : 751-755

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome?

By Binder Helge   Flegel Willy A   Emran Jasmin   Müller Andreas   Cupisti Susanne   Beckmann Matthias W   Eckstein Reinhold   Dittrich Ralf   Ringwald Juergen  

Reproductive BioMedicine Online, Vol. 17, Iss. 2, 2008-08 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Methylprednisolone reduces the risk of ovarian hyperstimulation syndrome (OHSS)

By  

Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Unilateral ovarian drilling in polycystic ovarian syndrome: a prospective randomized study

By Youssef Hamed   Atallah Magdy M  

Reproductive BioMedicine Online, Vol. 15, Iss. 4, 2007-10 ,pp. : 457-462

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Pituitary gonadotropins: Ovarian hyperstimulation syndrome, treated with cabergoline and ganirelix: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1280, 2009-01 ,pp. : 37-38

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of ovarian hyperstimulation syndrome

By Genazzani Andrea Riccardo   Monteleone Patrizia   Papini Francesca   Artini Paolo Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2527-2534

Informa Healthcare

Access to resources Recommend Favorite